ASP7374

BIOLOGICAL5 trials

Sponsors

UMN Pharma Inc.

Conditions

HealthyImmunogenicity of ASP7374InfluenzaVaccine

Phase 1

A Study to Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult Volunteers

CompletedNCT01393951

UMN Pharma Inc.Healthy, Immunogenicity of ASP7374

Start: 2011-05-31End: 2011-12-31Updated: 2017-09-29

Phase 3

Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine

CompletedNCT01767896

UMN Pharma Inc.Influenza

Start: 2012-10-31End: 2013-03-31Updated: 2017-09-29

A Study to Evaluate Intramuscular ASP7374

CompletedNCT01961960

UMN Pharma Inc.Influenza, Vaccine

Start: 2013-10-31End: 2013-11-30Updated: 2017-09-29

Study of ASP7374, Cell-culture-derived Influenza Vaccine

CompletedNCT01961947

UMN Pharma Inc.Influenza, Vaccine

Start: 2013-10-31End: 2013-11-30Updated: 2017-09-29

A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older

CompletedNCT02366962

UMN Pharma Inc.Influenza, Vaccine

Start: 2015-02-28End: 2015-04-30Updated: 2017-09-29